Eliminating the “expensive” adjective for clinical trials
- 1 April 2014
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 167 (4) , 419-420
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- DETermination of the role of OXygen in suspected Acute Myocardial Infarction trialAmerican Heart Journal, 2014
- Publication of Trials Funded by the National Heart, Lung, and Blood InstituteNew England Journal of Medicine, 2013
- When It Comes to Trials, Do We Get What We Pay For?New England Journal of Medicine, 2013
- The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?New England Journal of Medicine, 2013
- Thrombus Aspiration during ST-Segment Elevation Myocardial InfarctionNew England Journal of Medicine, 2013
- Targeted versus Universal Decolonization to Prevent ICU InfectionNew England Journal of Medicine, 2013
- Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trialThe Lancet, 2013
- Full Coverage for Preventive Medications after Myocardial InfarctionNew England Journal of Medicine, 2011
- Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationaleAmerican Heart Journal, 2010
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002